Article

PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons

Department of Physiology and Pharmacology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROC.
Biochimica et Biophysica Acta (Impact Factor: 4.66). 03/2011; 1812(6):674-84. DOI: 10.1016/j.bbadis.2011.03.007
Source: PubMed

ABSTRACT Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase. Autosomal recessive inheritance indicates the involvement of loss of PINK1 function in PARK6 pathogenesis. In the present study, confocal imaging of cultured SN dopaminergic neurons prepared from PINK1 knockout mice was performed to investigate physiological importance of PINK1 in maintaining mitochondrial membrane potential (ΔΨ(m)) and mitochondrial morphology and test the hypothesis that PARK6 mutations cause the loss of PINK1 function. PINK1-deficient SN dopaminergic neurons exhibited a depolarized ΔΨ(m). In contrast to long thread-like mitochondria of wild-type neurons, fragmented mitochondria were observed from PINK1-null SN dopaminergic cells. Basal level of mitochondrial superoxide and oxidative stressor H(2)O(2)-induced ROS generation were significantly increased in PINK1-deficient dopaminergic neurons. Overexpression of wild-type PINK1 restored hyperpolarized ΔΨ(m) and thread-like mitochondrial morphology and inhibited ROS formation in PINK1-null dopaminergic cells. PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons. Mitochondrial toxin rotenone-induced cell death of dopaminergic neurons was augmented in PINK1-null SN neuronal culture. These results indicate that PINK1 is required for maintaining normal ΔΨ(m) and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation. Our study also provides the evidence that PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1 is defective in regulating mitochondrial functions and attenuating ROS production of SN dopaminergic cells.

Download full-text

Full-text

Available from: Chin-Song Lu, Aug 11, 2014
0 Followers
 · 
84 Views
  • Source
    • "Thedecreaseinmitochondrialmembranepotentialisnotdueto aprotonleak,buttorespiratorychaindefectslikecomplexIand complexIIIdeficiency(Amoetal.,2011,2014).Therefore,PINK1 isrequiredformaintainingnormalmitochondrialmorphology ofSNpcDAneuronsincultureandexertsitsneuroprotective effectbyinhibitingROSformation(Wangetal.,2011).Inanimal models,studiesshowthatthelackofPINK1resultedinabnormal mitochondrialmorphology,lossofSNpcDAneurons,reduction incomplexIactivity,andenhancedvulnerabilitytooxidative stress(Clarketal.,2006;Kitadaetal.,2007;Gautieretal.,2008). Thesedefectscanbeamelioratedandrescuedbytheenhanced expressionofparkin(Yangetal.,2006;Exneretal.,2007).This lastscenarioseemstoinvolvePINK1andParkininacommon pathwaythatregulatesmitochondrialphysiologyandcellsurvival inwhichPINK1seemstobefunctioningupstreamofParkin,at leastasobservedinDrosophiladiseasemodels(Clarketal.,2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson disease (PD) is a chronic, progressive neurological disease that is associated with a loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. The molecular mechanisms underlying the loss of these neurons still remain elusive. Oxidative stress is thought to play an important role in dopaminergic neurotoxicity. Complex I deficiencies of the respiratory chain account for the majority of unfavorable neuronal degeneration in PD. Environmental factors, such as neurotoxins, pesticides, insecticides, dopamine (DA) itself, and genetic mutations in PD-associated proteins contribute to mitochondrial dysfunction which precedes reactive oxygen species formation. In this mini review, we give an update of the classical pathways involving these mechanisms of neurodegeneration, the biochemical and molecular events that mediate or regulate DA neuronal vulnerability, and the role of PD-related gene products in modulating cellular responses to oxidative stress in the course of the neurodegenerative process.
    Frontiers in Neuroanatomy 07/2015; 9(91). DOI:10.3389/fnana.2015.00091 · 4.18 Impact Factor
  • Source
    • "Rotenone has a direct effect on mitochondrial functions, including an interference with the electron transport chain, loss of mitochondrial membrane's potential, and ATP generation (Greenamyre et al. 2003; Sarafian et al. 2010; Simpkins et al. 2010). These cellular processes in turn cause the release of cytochrome C from the inner mitochondrial membrane, thus activating apoptotic effectors such as Bid, Bax, caspase 3, and 9 in neurons (Gyulkhandanyan et al. 2003; Swarnkar et al. 2012; Tiwari et al. 2011; Wang et al. 2011). Similarly, our experiments showed that 50 lM rotenone drastically affected cell Fig. 6 PDGF-BB pretreatment attenuated peroxide production after rotenone treatment. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Rotenone is one of the most-studied neurotoxic substances as it induces oxidative stress processes both in cellular and animal models. Rotenone affects ATP generation, reactive oxygen species (ROS) production, and mitochondrial membrane potential in neurons and astrocyte-like cells. Previous epidemiologic studies have supported the role of neurotrophic factors such as BDNF and GDNF in neuroprotection mainly in neurons; however, only very few studies have focused on the importance of astrocytic protection in neurodegenerative models. In the present study, we assessed the neuroprotective effects of PDGF-BB against toxicity induced by rotenone in the astrocytic-like model of T98G human glioblastoma cell line. Our results demonstrated that pretreatment with PDGF-BB for 24 h increased cell viability, preserved nuclear morphology and mitochondrial membrane potential following stimulation with rotenone, and reduced ROS production nearly to control conditions. These observations were accompanied by important morphological changes induced by rotenone and that PDGF-BB was able to preserve cellular morphology under this toxic stimuli. These findings indicated that PDGF-BB protects mitochondrial functions, and may serve as a potential therapeutic strategy in rotenone-induced oxidative damage in astrocytes.
    Neurotoxicity Research 12/2014; 27(4). DOI:10.1007/s12640-014-9509-5 · 3.15 Impact Factor
  • Source
    • "TMRM was excited at 543 nm with a HeNe green laser, and the emitted fluorescent signal at 560–620 nm was collected. Z-stacks of 15 confocal TMRM fluorescence images (with an acquisition interval along the z-axis of 0.3 μm) were processed and analyzed by LAS AF software (Leica) as previously described (Wang et al., 2011). Confocal MitoSox Red staining was performed to visualize mitochondrial level of superoxide anion in SH-SY5Y cells and SN dopaminergic neurons. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Many studies have shown that mitochondrial aldehyde dehydrogenase 2 (ALDH2) functions as a cellular protector against oxidative stress by detoxification of cytotoxic aldehydes. Within dopaminergic neurons, dopamine is metabolized by monoamine oxidase to yield 3,4-dihydroxyphenylacetaldehyde (DOPAL) then converts to a less toxic acid product by ALDH. The highly toxic and reactive DOPAL has been hypothesized to contribute to the selective neurodegeneration in Parkinson's disease (PD). In this study, we investigated the neuroprotective mechanism and therapeutic effect of ALDH2 in rotenone models for parkinsonism. Overexpression of wild-type ALDH2 gene, but not the enzymatically deficient mutant ALDH2*2 (E504K), reduced rotenone-induced cell death. Application of a potent activator of ALDH2, Alda-1, was effective in protecting against rotenone-induced apoptotic cell death in both SH-SY5Y cells and primary cultured substantia nigra (SN) dopaminergic neurons. In addition, intraperitoneal administration of Alda-1 significantly reduced rotenone- or MPTP-induced death of SN tyrosine hydroxylase (TH)-positive dopaminergic neurons. The attenuation of rotenone-induced apoptosis by Alda-1 resulted from decreasing ROS accumulation, reversal of mitochondrial membrane potential depolarization, and inhibition of activation of proteins related to mitochondrial apoptotic pathway. The present study demonstrates that ALDH2 plays a crucial role in maintaining normal mitochondrial function to protect against neurotoxicity and that Alda-1 is effective in ameliorating mitochondrial dysfunction and inhibiting mitochondria-mediated apoptotic pathway. These results indicate that ALDH2 activation could be a neuroprotective therapy for PD.
    Experimental Neurology 09/2014; 263. DOI:10.1016/j.expneurol.2014.09.016 · 4.62 Impact Factor
Show more